B12, folate and iron Flashcards

1
Q

What two carrier proteins bind B12 in the blood?

A

○ 10-30% bound to transcobalamin.

  • “Holotranscobalamin”
  • Metabolically active form of cobalamin.
  • > 90% of absorbed cobalamin will bind to transcobalamin and will be rapidly cleared from the circulation

○ 70-90% bound to haptocorrin

  • Metabolically inactive form, may represent the storage form of B12.
  • Low turnover/ slow clearance from the plasma.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

In man, B12 is required as a cofactor/ coenzyme for which two reactions?

A

1) As methylcobalamin as a cofactor for methionine synthatase.
(conversion of homocysteine to methionine)

2) As adenosyl cobalamin as a cofactor for the enzyme methylmalonyl-coA mutase.
(conversion of MMA to succinyl co-A)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How is homocysteine converted to methionine?

A
  • 5-MTHR donates a methyl group to cobalamin to form methylcobalamin
  • Methylcobalamin used as a cofactor for methionine synthetase to enable conversion of homocysteine to methionine.
  • This pathway is a vital source of methyl groups critical for a series of methylation reactions involving proteins, phospholipids, neurotransmitters and both RNA and DNA.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does folate do in the body?

A

• Folates participate in 1-carbon metabolism and are therefore essential for DNA synthesis.
○ Necessary for dTMP synthesis (thymidine).
○ In the absence of folic acid, dUMP (uracil in RNA) cannot be converted to dTMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does vitamin B12 deficiency cause a functional deficiency in folate?

A
  • While 5-MTHF is the metabolically active form of folate, it needs to be converted to 5-10, methylene THF for pyrimidine synthesis.
  • This conversion requires B12.
  • Cobalamin deficiency traps folate in the 5-MTHF state leading to a reduction in 5,10 MTHF.
  • This causes a block in the rate limiting step of DNA synthesis: production of dTMP.
  • 5-MTHF is a very poor substrate of the enzyme responsible for folate polyglutamation which is necessary to keep folate in the cells.
  • Folate therefore leaves the cells and enters the serum resulting in a high serum folate and low red cell folate in B12 deficiency.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are some of the issues with B12 assays?

A

• Issues with “grey zone” or mildly reduced B12 levels.

  • Generates a high number of false positive results
  • Poor positive predictive value
  • Significant limitations in pregnant patients: cobalamin levels fall by ~50% at term (haemodilution, fall in haptocorrins).
  • False negative can occur in those with a high level of anti-IF antibodies

• Difficulty defining sensitivity and specificity due to difficulty in defining a truly deficient standard.
○ MMA often used as a gold standard.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some of the issues with folate assays?

A

• Altered by acute dietary change and interruption of enterohepatic circulation.
- Serum levels can be low without tissue deficiency.

  • Red cell folate better reflects folate levels over the lifespan of the red cell (although there is little to be gained in testing red cell folate in the majority of people)
  • Haemolysis will cause a significant increase in serum folate (folate stored in RBCs released into the serum).
  • MTX and folinic acid interfere with folate measurement (cross react with folate binding proteins).
  • High triglycerides and bilirubin also interfere with the assay.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the steps of the B12/ cobalamin assay?

A

1) Alkaline hydrolysis (NaOH) used to release cobalamin from binders (haptocorrin and transcobalamin)
2) Synthetic cobalamin (complexed to a chemiluminescent or fluorescent substrate or enzyme) and IF added.
3) Patients serum B12 competes with labelled B12 for binding on IF.
4) IF is bound to a solid phase or coated onto magnetic beads.
5) Unbound ligand washed away
6) Conjugate to the labelled B12 added

7) Substrate added which binds the conjugate and creates chemiluminescence that is proportional to the amount of labelled B12 present.
- Inverse relationship between the quantity of patient B12 present and the amount of luminescence generated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How is the serum folate assay performed?

A

1) Alkaline denaturation to remove binders
2) Synthetic folate (complexed to a chemiluminescent or fluorescent substrate or enzyme) and B lactoglobin (a folate binding protein) added.
3) Patients serum folate competes with chemiluminescent or enzyme labelled folate for binding sites on FBP
4) FBP is bound to a solid phase or coated onto magnetic beads.
5) Unbound ligand washed away
6) Conjugate to the labelled folic acid added

7) Substrate added which binds the conjugate and creates chemiluminescence that is proportional to the amount of labelled folate present.
- Inverse relationship between the quantity of patient folate present and the amount of luminescence generated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Discuss MMA measurement

A
  • Quantified by gas chromatography- mass spectrometry. High cost.
  • Plasma or serum MMA is extracted, purified and using derivatives of MMA, measured by gas chromatography mass spec.
  • A stable isotype of MMA is used as an internal standard.

• Not specific. Also elevated with renal failure and small bowel bacterial overgrowth
Is probably still more useful than homocysteine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Discuss Homocysteine measurement

A
  • Sample must be kept cool and centrifuged within two hours of collection
  • Can be measured by an immunoassay, competitive binding assay or enzyme immunoassay.

•Not specific. Also elevated with folate deficiency, B6 deficiency, renal failure, hypothyroidism and certain genetic abnormalities.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Discuss holotranscobalamin “Active B12”Immunoassay

A

• Two step quantitative immunoassay
○ Sample and anti-holotranscobalamin coated beads combined. Holotranscobalamin in the sample binds to the beads.
○ Sample washed
○ Anti-transcobalamin labelled conjugate added
○ Sample washed
○ Substrate added
○ Resulting chemiluminescent reaction measured.

• Appears to perform better than serum B12 based on MMA levels
○ Smaller grey zone
○ Better sensitivity and specificity (when MMA used as a gold standard)
○ Not affected by pregnancy, the OCP
○ Place still not clearly established

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How are the tests of B12 deficiency affected by pregnancy?

A

· Spuriously low serum vitamin B12 when total B12 is measured (reduced haptocorrin in pregnancy). Levels fall as pregnancy progresses and are the lowest just before delivery.

· Holotranscobalamin measures the metabolically active form of transcobalamin. Better sensitivity and specificity than total B12, not affected by pregnancy (or oral contraceptive use)

· Plasma homocysteine and methylmalonic acid levels:

  • Plasma MMA more specific. Homocysteine elevated in a variety of conditions.
  • Levels of both can be affected by pregnancy with a gradual increase seen in both levels as pregnancy proceeds to term.
  • Haemodilution may affect homocysteine results
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the chemical symbols for ferric and ferrous iron?

A
  • Ferric Fe3+

- Ferrous Fe2+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How is serum iron measured?

A

○ Measured via a colourimetric assay.

  • Elemental iron is removed from transferrin in the presence of acid.
  • The released Fe3+ is then reduced with ascorbic acid to Fe2+
  • Fe2+ reacts with an added chromogen to form a coloured complex.
  • This complex is then measured. The colour change is directly proportional to the amount of Fe2+.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the transferrin saturation?
What causes a low transferrin saturation?
What causes a high transferrin level?

A

○ Serum iron divided by the total iron-binding capacity, expressed as a percentage.
○ Provides an estimate of how much iron is bound to the available transferrin

○ Low levels are seen in iron deficiency, inflammation, infection and chronic disease.
○ High levels seen in and specific for iron overload (as it is dependent upon serum iron, anything which increases serum iron increases the transferrin sat)

17
Q

How is TIBC measured?

A
  • Old index. Quantitated by first measuring iron in sample, then adding excess iron, removing unbound iron and remeasuring iron
  • Now commonly measure transferrin (by an immunoassay) and calculate TIBC
18
Q

How is ferritin measured?

A
  • Sandwiched immunoassay
  • Two different antibodies to ferritin used: form a sandwich around the ferritin complex. The primary antibody is biotinylated.
  • Complexes bind to streptavidin magnetic particles (via the biotinylated antibody).
  • After washing, voltage applied to electrode.
  • Chemiluminescent emission measured by PMT

Can also be measured using an immunoturbidimetric assay.

19
Q

What are the disadvantages to the soluble transferrin assay?

A

Cost
Analytical issues (no reference measurement procedure, no standardisation of assays (although WHO reference reagent available)
Limited availability.
Increased levels seen in any condition with increased erythropoietic drive (haemolysis, thalassaemia)

Ferritin index may improve diagnostic performance:
solTfR/ log ferritin ratio

20
Q

How is hepcidin measured?

What are some of the issues with hepcidin measurement?

A
  • Mass spec assay: distinguishes between the bioactive isoform and other inactive isoforms of hepcidin
  • Immunoassay: measures total hepcidin

○ No standardisation.

  • No primary reference material
  • No reference method
  • No computable calibrator

○ Wide variation in hepcidin measurement (assays vary up to 10x in absolute hepcidin).
○ Wide biological variation (increases with fasting, circadian rhythm, wide range of stimulatory and inhibitory mediators.

21
Q

What are the different types of hereditary iron overload?

A

Type 1 = HH
Type 1a: HFE C282Y Homozygous
Type 1b: HFE C282Y/H63D
Type 1c: HFE S65C

Type 2= Juvenile HH
Type 2A: HJV (haemojuvelin, involved in hepcidin syn)
Type 2B: HAMP (hepcidin)

Type 3= Transferrin receptor 2 (TFR2)

Type 4 = Ferroportin disease

22
Q

What is the advice around screening for hereditary haemochromatosis?

A

· Selective screening of first-degree relatives of patients affected with type 1HH is suggested.

· For children of an identified proband, HFE testing of the other parent is generally recommended, and if results are normal, the child is an obligate heterozygote and need not undergo further testing.

· If the other parent cannot be tested, then the child need not be tested until age 18 years, because clinical manifestations of HH rarely present beforehand.

23
Q

Discuss the utility of liver biopsy in those presenting with a ferritin level >1000

A

o Risk of developing cirrhosis rises significantly with SF levels of >1,000 ng/mL at diagnosis.

o Primary utility of liver biopsy in HH is for staging of fibrosis
o T2-weighted MRI imaging can be used to diagnose iron overload due to HH and to estimate hepatic iron concentration noninvasively
- It is now suggested that MRI in conjunction with software used for the estimation of HIC (i.e., MRI T2) be used to non-invasively measure liver iron concentration in the non-C282Y homozygote with suspected iron overload.
o If there is a concomitant need to stage hepatic fibrosis or evaluate for alternate liver diseases, then liver biopsy is the preferred method.

24
Q

What is anaemia of inflammation/ chronic disease?

A

• Mild to moderate anaemia that develops in the context of systemic inflammation because of decreased production of erythrocytes and a moderate reduction in erythrocyte survival.

• Primarily a disorder of iron distribution.
- Low serum iron levels but preserved iron stores in bone marrow, splenic and hepatic macrophages.

25
Q

What is the pathogenesis of anaemia of inflammation/ chronic disease?

A

Cytokines restrict erythropoiesis:

  • Directly by suppressing production of erythropoietin and reducing erythroid transcription factors
  • Indirectly by causing functional iron deficiency due to increased hepcidin synthesis (predominately via IL6). Inflammatory hypoferraemia has an inhibitory effect on erythropoiesis (at a transferrin saturation of 15-20%).

And shorten the erythrocyte lifespan (to approximately 90 days).